![Elise Chemin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Elise Chemin
Anciens postes connus de Elise Chemin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Weinberg Capital Partners SAS
![]() Weinberg Capital Partners SAS Investment ManagersFinance Weinberg Capital Partners SAS (WCP) is a private equity firm founded in 2005 by Serge Weinberg and Philippe Klocanas. The firm is headquartered in Paris, France. | Analyste en capital-investissement | 01/01/2008 | 01/04/2012 |
Mutabilis SA
![]() Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Directeur/Membre du Conseil | 17/02/2011 | - |
Statistiques
Internationale
France | 3 |
Opérationnelle
Private Equity Analyst | 1 |
Director/Board Member | 1 |
Sectorielle
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Weinberg Capital Partners SAS
![]() Weinberg Capital Partners SAS Investment ManagersFinance Weinberg Capital Partners SAS (WCP) is a private equity firm founded in 2005 by Serge Weinberg and Philippe Klocanas. The firm is headquartered in Paris, France. | Finance |
Mutabilis SA
![]() Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Health Technology |
- Bourse
- Insiders
- Elise Chemin
- Expérience